건강한 성인에서 인플루엔자 백신의 근육내 주사와 절반 용량 피부내 주사의 면역원성과 안전성 비교 = Immunogenicity and Safety of Half Dose Intradermal Injection Compared to Full Dose Intramuscular Injection of Influenza Vaccine in Healthy Adults

참고문헌 (Reference)

1 "U.S. will miss half its supply of flu vaccine" New York Times 2004

2 "Serum antibody responses after intradermal vaccination against influenza" 351 : 2286-2294, 2004

3 "Safety and immunogenicity of an inactivated subvirion influenza A(H5N1)vaccine" 354 : 1343-1351, 2006

4 "Prevention and Control of Influenza : Recommendations of the Advisory Committee on Immunization Practices (ACIP)" 54 : 1-40, 2005

5 "Note for Guidance on Harmonization of Requirements for Influenza Vaccines" CPMP/BWP/214 1997

6 "Intradermal injection, as opposed to subcutaneous injection, enhances immunogenicity and suppresses tumorigenicity of tumor cells" 63 : 2145-2149, 2003

7 "Intradermal hepatitis B vaccination in a large hospital employee population" 723-9 7, 1991

8 "Influenza: a preventable lethal disease" 57 : 627-628, 2002

9 "Influenza vaccines" 77 : 230-239, 2002

10 "Immunogenicity and protective efficacy of influenza vaccination" 103 : 133-138, 2004

11 "Hopeful news on human H5N1 vaccine, but production concerns considerable" CIDRAP News 2005

12 "Epidermal Langerhans cells: from neurons to nature's adjuvants" 14 : 209-258, 1999

13 "Dose sparing with intradermal injection of influenza vaccine" 351 : 2295-2301, 2004

14 "Comparison of higher- dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers" 21 : 264-269, 2000

15 "Avian influenza A(H5N1) infection in humans" 353 : 1374-1385, 2005

16 "2004-2005 Guideline for control and prevention of influenza" Korea Center for Disease Control and Prevention